Literature DB >> 15773658

The compatibility of ceramic bone graft substitutes as allograft extenders for use in impaction grafting of the femur.

A W Blom1, J L Cunningham, G Hughes, T J Lawes, N Smith, G Blunn, I D Learmonth, A E Goodship.   

Abstract

This study investigates the use of porous biphasic ceramics as graft extenders in impaction grafting of the femur during revision hip surgery. Impaction grafting of the femur was performed in four groups of sheep. Group one received pure allograft, group two 50% allograft and 50% BoneSave, group three 50% allograft and 50% BoneSave type 2 and group four 10% allograft and 90% BoneSave as the graft material. Function was assessed using an index of pre- and post-operative peak vertical ground reaction force ratios. Changes in bone mineral density were measured by dual energy X ray absorptiometry (DEXA) scanning. Loosening and subsidence were assessed radiographically and by histological examination of the explanted specimens. There was no statistically significant difference between the four groups after 18 months of unrestricted functional loading for all outcome measures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773658     DOI: 10.1302/0301-620x.87b3.14337

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  10 in total

1.  [Analysis of the effectiveness of an internal hospital bone bank].

Authors:  M Flören; T Kappe; H Reichel
Journal:  Orthopade       Date:  2007-07       Impact factor: 1.087

2.  Mechanical properties of morcellised bone graft with the addition of hydroxyapatite.

Authors:  I McNamara; J Howard; A Rayment; R Schalk; R Brooks; S Best; N Rushton
Journal:  J Mater Sci Mater Med       Date:  2014-01-05       Impact factor: 3.896

3.  Bone graft materials for posterolateral fusion made simple: a systematic review.

Authors:  Matthew T Morris; Sandip P Tarpada; Woojin Cho
Journal:  Eur Spine J       Date:  2018-02-14       Impact factor: 3.134

4.  Revision of Total Hip Arthroplasty with Acetabular Bone Defects: Are Biological Grafts Really Better than Synthetic Bone Graft Substitutes?

Authors:  Luca Costanzo Comba; Enrico Bellato; Danilo Colombero; Lorenzo Mattei; Antongiulio Marmotti; Filippo Castoldi
Journal:  Arch Bone Jt Surg       Date:  2022-07

5.  Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications.

Authors:  Gráinne Neary; Ashley W Blom; Anna I Shiel; Gabrielle Wheway; Jason P Mansell
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

6.  Impaction grafting of the acetabulum with ceramic bone graft substitute: high survivorship in 43 patients with a mean follow-up period of 4 years.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-08       Impact factor: 3.717

Review 7.  Bone substitutes in orthopaedic surgery: from basic science to clinical practice.

Authors:  V Campana; G Milano; E Pagano; M Barba; C Cicione; G Salonna; W Lattanzi; G Logroscino
Journal:  J Mater Sci Mater Med       Date:  2014-05-28       Impact factor: 3.896

8.  Preparation and characterization of cockle shell aragonite nanocomposite porous 3D scaffolds for bone repair.

Authors:  Saffanah Khuder Mahmood; Md Zuki Abu Bakar Zakaria; Intan Shameha Binti Abdul Razak; Loqman Mohamed Yusof; Alhaji Zubair Jaji; Isa Tijani; Nahidah Ibrahim Hammadi
Journal:  Biochem Biophys Rep       Date:  2017-04-23

9.  Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute.

Authors:  Ashley W Blom; Vikki Wylde; Christine Livesey; Michael R Whitehouse; Steve Eastaugh-Waring; Gordon C Bannister; Ian D Learmonth
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

10.  Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: high survivorship in 43 patients with a median follow-up of 7 years: a follow-up report.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-04-17       Impact factor: 3.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.